SARS-COV-2 infection in patients with cancer undergoing checkpoint blockade: Clinical course and outcome.
PubWeight™: 0.75‹?›
Published in Eur J Cancer on May 03, 2020
Author Affiliations
1: Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy.
2: Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy; NIBIT Foundation Onlus, Italy. Electronic address: mmaiocro@gmail.com.